BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29178579)

  • 1. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
    Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
    Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma.
    Sánchez-Céspedes R; Fernández-Martínez MD; Raya AI; Pineda C; López I; Millán Y
    BMC Vet Res; 2021 May; 17(1):197. PubMed ID: 34034728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
    Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
    J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
    Mainenti M; Rasotto R; Carnier P; Zappulli V
    Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on canine mammary tumours. II. Oestradiol and progesterone receptor binding capacity and histological type.
    Boldizsár H; Muray T; Számel I; Szenci O; Csenki J
    Acta Vet Hung; 1992; 40(1-2):89-97. PubMed ID: 1476094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinicopathological characteristics and oestrogen receptor gene expression in oestrogen receptor-negative, progesterone receptor-positive canine mammary carcinomas.
    Kim NH; Lim HY; Im KS; Shin JI; Kim HW; Sur JH
    J Comp Pathol; 2014 Jul; 151(1):42-50. PubMed ID: 24913515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours.
    Geraldes M; Gärtner F; Schmitt F
    Vet Rec; 2000 Apr; 146(14):403-6. PubMed ID: 10791469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland.
    Lantinga-van Leeuwen IS; van Garderen E; Rutteman GR; Mol JA
    J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):219-28. PubMed ID: 11282275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic value of c-met in canine mammary tumours.
    Chen YC; Chen YY; Liao JW; Chang SC
    Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
    Pastor N; Ezquerra LJ; Santella M; Caballé NC; Tarazona R; Durán ME
    Vet Comp Oncol; 2020 Dec; 18(4):753-762. PubMed ID: 32336005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
    Gama A; Gärtner F; Alves A; Schmitt F
    Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine Mixed Mammary Tumour as a Model for Human Breast Cancer with Osseous Metaplasia.
    Saad ES; Milley KM; Al-Khan AA; Nimmo JS; Bacci B; Tayebi M; Day MJ; Richardson SJ; Danks JA
    J Comp Pathol; 2017 May; 156(4):352-365. PubMed ID: 28449818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.
    Kim NH; Lim HY; Im KS; Kim JH; Sur JH
    J Comp Pathol; 2013 May; 148(4):298-306. PubMed ID: 23079102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary gland tumors in male dogs.
    Saba CF; Rogers KS; Newman SJ; Mauldin GE; Vail DM
    J Vet Intern Med; 2007; 21(5):1056-9. PubMed ID: 17939564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
    Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.